Reports on B-Cell Lymphoma from Sungkyunkwan University School of Medicine Provide New Insights (Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma)

Media coverage

• Title	Reports on B-Cell Lymphoma from Sungkyunkwan University School of Medicine Provide New Insights (Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	26.03.27
  Persons	Young Min Kim